Back to Compound Explorer

Sodium Pyroglutamate

Preliminary

Mechanism of Action

Sodium pyroglutamate exerts anti-angiogenic effects by inhibiting von Willebrand Factor (vWF) expression in tumor-associated vasculature, disrupting platelet adhesion and endothelial cell recruitment necessary for neovascularization. It also inhibits cancer-induced immune suppression by preventing the downregulation of cytotoxic T-cell activity that tumors typically induce through immunosuppressive cytokine secretion (TGF-β, IL-10).

Research Notes

Anti-angiogenic and immune-protective activity was demonstrated in Lewis lung carcinoma mouse models, where oral sodium pyroglutamate supplementation reduced tumor vascularity and maintained cytotoxic T-cell function. The compound showed particular efficacy in pre-initiation protection paradigms. No human clinical trials have been conducted.

Found In 1 Herb

3D Molecular Structure

Amino acid derivative
Drag to rotate · Click atoms to explore

Sodium Pyroglutamate

Amino acid derivativeBioactive phytochemical with therapeutic properties

Representative pattern: C₄H₂NO

Atoms
Carbon
Oxygen
Nitrogen
Hydrogen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.